Lotus Pharmaceutical Co Ltd
Lotus Pharmaceutical's GHG Emissions Data Preview
In 2023, Lotus Pharmaceutical completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Lotus Pharmaceutical has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Lotus Pharmaceutical's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Lotus Pharmaceutical amounted to 15,439.893 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Lotus Pharmaceutical decreased by 27.54%, showing that the company has made progress in taking action to reduce the climate impact of its operations.
Lotus Pharmaceutical's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Lotus Pharmaceutical's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Lotus Pharmaceutical were 3,310.317 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Compared to the previous year (2022), Lotus Pharmaceutical's Scope 1 emissions decreased by 68.95%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.
What are Lotus Pharmaceutical's Scope 2 emissions?
In 2023, Lotus Pharmaceutical reported Scope 2 greenhouse gas (GHG) emissions of 12,129.576 tCOâ‚‚e without specifying the calculation method.
Has Lotus Pharmaceutical reduced its Scope 2 emissions over time?
Compared to the previous year (2022), Lotus Pharmaceutical's Scope 2 emissions (Unspecified Calculation Method) rose by 13.92% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy
What methodology does Lotus Pharmaceutical use for Scope 2 reporting?
In 2023, Lotus Pharmaceutical reported its Scope 2 emissions using an unspecified methodology.
Lotus Pharmaceutical's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)